Drug Target ID builds comprehensive molecular signaling landscapes underlying complex genetic disorders to reveal your novel diagnostic biomarkers and druggable targets.

DTID declares no conflict of interest in PRIME.

Contact
Member Login
Legal Disclaimer

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847879.
This website reflects only the view of the authors and the European Commission is not responsible for any use that may be made of the information it contains‍.
‍
© 2021 PRIME